Treatment · March 29, 2026
New Triple Action Weight Loss Drug Shows Promise in Advanced Trials
An experimental weight loss drug shows transformative potential for patients seeking new treatment options....
Treatment · March 22, 2026
FDA Approves Higher-Dose Semaglutide for Weight Management Following Accelerated Review
Higher-dose semaglutide receives FDA approval through accelerated review, expanding treatment options....
Treatment · March 19, 2026
Shanghai Firm's Diabetes Drug Gains First Approval in Hong Kong
A Shanghai firm's innovative diabetes drug gains approval in Hong Kong, offering patients a new treatment option....
Treatment · September 1, 2025
Chinese Diabetes Treatments Gain Global Traction After Domestic Success
Significant advances in type 2 diabetes treatments developed in China are now spreading globally to benefit patients worldwide....